Sartorius Stedim Biotech

Transaction in Own Shares • Jan 6, 2026

News Details

FR Regulatory | 6 January 2026 10:23

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech

Sartorius Stedim Biotech SA

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech

06-Jan-2026 / 10:23 CET/CEST

Dissemination of a French Regulatory News, transmitted by EQS Group .

The issuer is solely responsible for the content of this announcement.

---

Aubagne, January 6, 2026

Half-year liquidity contract statement for Sartorius Stedim Biotech

Under the liquidity contract entered into between Sartorius Stedim Biotech and Kepler Cheuvreux, the following resources appeared on the liquidity account on December 31st 2025:

• 32,966 shares
• €6,457,086.94
• Number of executions on buy side on semester: 5,079
• Number of executions on sell side on semester: 4,845
• Traded volume on buy side on semester: 272,457 shares for €51,769,936.60
• Traded volume on sell side on semester: 275,047 shares for €52,809,559.69

As a reminder :

The following resources appeared on the last half year statement on 30 June 2025 on the liquidity account:

• 35,556 shares
• €5,371,198.80
• Number of executions on buy side on semester: 6,590
• Number of executions on sell side on semester: 6,093
• Traded volume on buy side on semester: 341,671 shares for €67,250,964.02
• Traded volume on sell side on semester: 335,678 shares for €66,313,031.28

The following resources appeared on the liquidity account when the activity started:

• 0 shares
• €10,000,000.00

The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.

A profile of Sartorius Stedim Biotech

Sartorius Stedim Biotech is a leading international partner to the biopharmaceutical industry. As a provider of innovative solutions, the company based in Aubagne, France, helps its customers to manufacture biotech medications, such as cell and gene therapies, more safely, rapidly, and sustainably. The shares of Sartorius Stedim Biotech S.A. are listed on the Euronext Paris. The company has a strong global reach with manufacturing and R&D sites as well as sales entities in Europe, North America, and Asia. Sartorius Stedim Biotech regularly expands its portfolio through acquisitions of complementary technologies. In 2024, the company generated sales revenue of around 2.8 billion euros. More than 9,900 employees work for customers around the globe.

Contact

Petra Müller

Head of Investor Relations

+49 (0)551.308.6035

Petra.mueller2@sartorius.com

Sartorius Stedim Biotech S.A.

Z.I. Les Paluds

Avenue de Jouques, CS 91051

13781 Aubagne Cedex, France

Phone: +33.(0)4.42.84.56.00

Fax: +33.(0)4.42.84.56.19

www.sartorius.com

	Buy side			Sell side
	Number of executions	Number of shares	Traded volume in EUR	Number of executions	Number of shares	Traded volume in EUR
Total	5,079	272,457	51,769,936.60	4,845	275,047	52,809,559.69
07/01/2025	78	3,628	728,030.76	47	3,000	604,320.00
07/02/2025	44	2,900	588,671.00	92	3,500	714,490.00
07/03/2025	42	2,919	598,190.67	46	2,600	535,392.00
07/04/2025	53	2,201	445,790.54	44	2,500	509,375.00
07/07/2025	47	3,193	641,569.49	23	1,200	241,656.00
07/08/2025	66	3,979	788,995.91	79	4,400	880,264.00
07/09/2025	34	1,900	382,223.00	62	3,300	668,316.00
07/10/2025	19	1,100	222,937.00	82	4,300	876,039.00
07/11/2025	59	3,300	672,408.00	31	1,607	328,776.13
07/14/2025	109	6,500	1,293,630.00	24	1,400	284,298.00
07/15/2025	48	2,930	580,989.70	58	2,800	559,692.00
07/16/2025	51	2,500	486,675.00	28	1,900	370,823.00
07/17/2025	54	3,000	581,070.00	36	1,715	333,498.90
07/18/2025	37	2,300	441,186.00	31	1,600	308,416.00
07/21/2025	66	3,400	641,308.00	37	2,300	436,448.00
07/22/2025	94	6,700	1,199,903.00	12	501	93,692.01
07/23/2025	63	4,700	827,811.00	32	1,801	319,479.39
07/24/2025	31	1,700	296,242.00	45	2,100	367,605.00
07/25/2025	40	1,600	279,024.00	28	1,600	279,632.00
07/28/2025	43	3,000	533,070.00	80	3,099	553,915.26
07/29/2025	19	1,300	230,152.00	65	4,400	786,500.00
07/30/2025	42	2,400	431,640.00	34	2,500	452,625.00
07/31/2025	69	3,500	622,020.00	24	1,700	304,062.00
08/01/2025	57	2,700	464,022.00	26	1,661	286,306.57
08/04/2025	53	2,422	413,798.70	35	1,700	291,346.00
08/05/2025	50	2,378	403,189.90	23	1,300	221,182.00
08/06/2025	56	2,800	469,448.00	25	1,310	220,525.40
08/07/2025	33	1,350	224,923.50	27	1,900	317,319.00
08/08/2025	49	2,400	400,752.00	46	1,900	318,364.00
08/11/2025	35	1,800	303,174.00	40	2,150	362,984.50
08/12/2025	8	700	120,659.00	96	5,189	900,602.84
08/13/2025	51	2,400	422,496.00	37	2,200	388,256.00
08/14/2025	27	1,400	246,876.00	35	2,000	354,580.00
08/15/2025	35	2,500	443,000.00	40	2,200	390,566.00
08/18/2025	53	2,600	459,056.00	40	2,500	442,600.00
08/19/2025	17	1,200	212,196.00	64	2,600	462,878.00
08/20/2025	35	1,300	232,726.00	38	1,800	323,208.00
08/21/2025	46	2,200	391,138.00	13	700	125,531.00
08/22/2025	33	1,200	211,860.00	47	2,600	462,878.00
08/25/2025	47	2,100	371,154.00	26	1,200	213,132.00
08/26/2025	58	1,621	283,610.16	35	1,818	319,513.50
08/27/2025	59	2,600	454,896.00	44	2,100	368,634.00
08/28/2025	46	2,400	419,952.00	34	1,912	335,441.28
08/29/2025	41	2,100	367,710.00	33	2,688	471,448.32
09/01/2025	19	800	141,808.00	20	1,182	210,195.06
09/02/2025	36	1,700	299,897.00	13	700	125,062.00

	Buy side			Sell side
	Number of executions	Number of shares	Traded volume in EUR	Number of executions	Number of shares	Traded volume in EUR
Total	5,079	272,457	51,769,936.60	4,845	275,047	52,809,559.69
09/03/2025	20	1,500	262,035.00	26	1,600	280,160.00
09/04/2025	66	3,289	562,353.22	37	2,500	430,175.00
09/05/2025	12	900	155,232.00	29	1,500	259,620.00
09/08/2025	20	1,200	208,440.00	27	1,200	208,800.00
09/09/2025	15	1,100	192,247.00	31	1,200	210,384.00
09/10/2025	20	1,000	175,220.00	16	800	140,624.00
09/11/2025	33	2,100	361,746.00	19	1,000	173,850.00
09/12/2025	19	1,303	221,835.75	25	1,400	239,414.00
09/15/2025	12	500	85,325.00	22	1,700	293,386.00
09/16/2025	34	1,600	281,280.00	26	1,800	318,186.00
09/17/2025	23	1,500	262,575.00	34	1,900	333,982.00
09/18/2025	–	–	–	25	1,600	289,008.00
09/19/2025	25	1,700	315,146.00	32	2,000	371,800.00
09/22/2025	36	2,100	389,550.00	25	1,443	268,282.56
09/23/2025	22	1,300	241,020.00	61	3,657	681,628.23
09/24/2025	70	3,800	699,960.00	21	1,100	204,325.00
09/25/2025	77	3,700	654,678.00	10	420	75,033.00
09/26/2025	54	3,250	560,885.00	23	1,500	260,385.00
09/29/2025	40	2,700	464,535.00	45	1,700	294,185.00
09/30/2025	35	2,397	404,685.51	52	3,100	527,713.00
10/01/2025	–	–	–	106	5,480	996,373.60
10/02/2025	29	1,750	332,465.00	73	4,099	782,253.16
10/03/2025	6	400	76,900.00	84	4,896	955,895.04
10/06/2025	46	2,352	463,485.12	48	2,800	553,532.00
10/07/2025	56	2,498	492,230.90	41	2,100	414,792.00
10/08/2025	49	3,500	675,080.00	24	1,400	271,026.00
10/09/2025	54	2,800	533,344.00	21	1,500	287,145.00
10/10/2025	68	3,173	600,395.06	42	2,400	456,456.00
10/13/2025	35	2,139	398,902.11	29	1,800	336,924.00
10/14/2025	83	3,088	564,455.52	31	2,000	366,180.00
10/15/2025	19	1,000	185,290.00	75	3,300	612,645.00
10/16/2025	–	–	–	127	7,598	1,551,587.58
10/17/2025	1	100	20,260.00	53	3,020	617,288.00
10/20/2025	34	1,950	395,187.00	54	2,500	510,925.00
10/21/2025	30	1,800	371,520.00	91	5,900	1,243,307.00
10/22/2025	45	2,238	469,644.30	51	3,250	688,577.50
10/23/2025	54	2,100	442,428.00	26	1,700	359,108.00
10/24/2025	36	1,500	316,140.00	34	1,700	359,771.00
10/27/2025	56	2,400	506,424.00	37	1,751	370,354.01
10/28/2025	62	3,300	694,452.00	49	3,249	688,333.14
10/29/2025	60	2,762	574,440.76	38	2,300	481,045.00
10/30/2025	51	2,900	602,736.00	27	1,789	373,901.00
10/31/2025	41	2,200	457,776.00	41	2,611	544,289.06
11/03/2025	58	4,000	816,360.00	13	1,100	227,117.00
11/04/2025	48	2,400	475,176.00	31	2,300	456,182.00
11/05/2025	78	3,670	715,576.60	12	1,000	195,950.00

	Buy side			Sell side
	Number of executions	Number of shares	Traded volume in EUR	Number of executions	Number of shares	Traded volume in EUR
Total	5,450	281,035	49,893,952.42	5,333	297,764	53,521,926.85
11/06/2025	42	2,500	481,350.00	17	902	175,709.60
11/07/2025	33	1,800	339,984.00	19	1,284	243,035.52
11/10/2025	35	2,000	377,620.00	36	1,702	322,614.10
11/11/2025	9	483	90,852.30	34	2,394	457,900.38
11/12/2025	34	2,200	426,580.00	49	2,901	564,099.45
11/13/2025	51	2,800	543,760.00	24	1,720	338,444.40
11/14/2025	38	905	172,710.20	10	700	134,050.00
11/17/2025	55	2,895	551,584.35	7	600	114,402.00
11/18/2025	75	2,517	466,626.63	27	1,446	269,679.00
11/19/2025	48	2,500	463,975.00	27	1,767	329,280.45
11/20/2025	24	2,000	371,920.00	50	2,368	441,750.40
11/21/2025	66	2,247	417,717.30	67	3,519	661,184.91
11/24/2025	23	1,200	232,140.00	69	3,301	640,294.97
11/25/2025	15	700	135,527.00	68	4,176	826,096.32
11/26/2025	44	3,200	645,344.00	34	1,816	368,648.00
11/27/2025	21	1,000	201,310.00	35	2,097	424,055.34
11/28/2025	7	400	81,380.00	29	1,287	263,796.39
12/01/2025	7	600	125,760.00	21	1,269	267,581.34
12/02/2025	46	2,580	533,569.80	43	2,900	602,243.00
12/03/2025	6	600	125,868.00	53	3,931	831,170.64
12/04/2025	50	2,900	618,715.00	37	2,200	472,692.00
12/05/2025	19	1,200	256,080.00	24	1,370	293,454.00
12/08/2025	31	2,300	488,911.00	17	1,300	277,589.00
12/09/2025	42	3,000	626,880.00	5	400	83,780.00
12/10/2025	35	2,400	504,192.00	36	2,600	549,614.00
12/11/2025	21	1,700	352,478.00	14	800	166,384.00
12/12/2025	29	1,400	286,370.00	12	1,010	208,150.90
12/15/2025	40	1,700	350,319.00	53	2,890	599,010.30
12/16/2025	45	1,842	382,270.26	49	3,100	647,032.00
12/17/2025	62	3,258	664,860.06	9	533	109,686.07
12/18/2025	43	2,050	415,596.50	29	1,800	365,868.00
12/19/2025	23	1,200	244,476.00	27	1,500	307,005.00
12/22/2025	19	1,200	244,404.00	24	1,867	382,622.98
12/23/2025	44	2,291	472,152.19	33	1,895	391,829.15
12/24/2025	12	509	104,787.83	14	870	179,324.40
12/29/2025	1	100	20,570.00	6	395	81,804.50
12/30/2025	–	–	–	9	340	71,080.40
12/31/2025	–	–	–	7	301	62,830.74

---

Regulatory filing PDF file

File: Half-year liquidity contract statement for Sartorius Stedim Biotech

- - -
Language:	English
Company:	Sartorius Stedim Biotech SA
	Avenue de Jouques
	13781 Aubagne
	France
Phone:	+33 44 284 5600
E-mail:	sartorius.presse@sartorius.com
Internet:	www.sartorius.com
ISIN:	FR0013154002
Euronext Ticker:	DIM
AMF Category:	Share buyback / Disposal of own shares / Information relating to the liquidity contract
EQS News ID:	2255304

End of Announcement	EQS News Service

---

2255304  06-Jan-2026 CET/CEST